Mark Lawler , Richard Sullivan , Ghassan K. Abou-Alfa , Karen McCloskey , Debbie Keatley , Jennifer Feighan , William Dahut , Eibhlin Mulroe , Robert Ladner , Mohamed Genead , Maeve Lowery , James L. Gulley , Christopher J. Scott , Daniel B. Longley , Aedin Culhane , William M. Gallagher , Nick Orr , Stephen J. Chanock , Satish Gopal
{"title":"健康外交在行动:耶稣受难日协议的癌症遗产。","authors":"Mark Lawler , Richard Sullivan , Ghassan K. Abou-Alfa , Karen McCloskey , Debbie Keatley , Jennifer Feighan , William Dahut , Eibhlin Mulroe , Robert Ladner , Mohamed Genead , Maeve Lowery , James L. Gulley , Christopher J. Scott , Daniel B. Longley , Aedin Culhane , William M. Gallagher , Nick Orr , Stephen J. Chanock , Satish Gopal","doi":"10.1016/j.jcpo.2023.100448","DOIUrl":null,"url":null,"abstract":"<div><p>2023 marks the 25th anniversary of the Good Friday Agreement, which led peace in Northern Ireland. As well as its impact on peace and reconciliation, the Good Friday Agreement has also had a lasting positive impact on cancer research and cancer care across the island of Ireland. Pursuant to the Good Friday Agreement, a Memorandum of Understanding (MOU) was signed between the respective Departments of Health in Ireland, Northern Ireland and the US National Cancer Institute (NCI), giving rise to the Ireland – Northern Ireland – National Cancer Institute Cancer Consortium, an unparalleled tripartite agreement designed to nurture and develop linkages between cancer researchers, physicians and allied healthcare professionals across Ireland, Northern Ireland and the US, delivering world class research and better care for cancer patients on the island of Ireland and driving research and innovation in the US.</p></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"38 ","pages":"Article 100448"},"PeriodicalIF":2.0000,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Health diplomacy in action: The cancer legacy of the Good Friday Agreement\",\"authors\":\"Mark Lawler , Richard Sullivan , Ghassan K. Abou-Alfa , Karen McCloskey , Debbie Keatley , Jennifer Feighan , William Dahut , Eibhlin Mulroe , Robert Ladner , Mohamed Genead , Maeve Lowery , James L. Gulley , Christopher J. Scott , Daniel B. Longley , Aedin Culhane , William M. Gallagher , Nick Orr , Stephen J. Chanock , Satish Gopal\",\"doi\":\"10.1016/j.jcpo.2023.100448\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>2023 marks the 25th anniversary of the Good Friday Agreement, which led peace in Northern Ireland. As well as its impact on peace and reconciliation, the Good Friday Agreement has also had a lasting positive impact on cancer research and cancer care across the island of Ireland. Pursuant to the Good Friday Agreement, a Memorandum of Understanding (MOU) was signed between the respective Departments of Health in Ireland, Northern Ireland and the US National Cancer Institute (NCI), giving rise to the Ireland – Northern Ireland – National Cancer Institute Cancer Consortium, an unparalleled tripartite agreement designed to nurture and develop linkages between cancer researchers, physicians and allied healthcare professionals across Ireland, Northern Ireland and the US, delivering world class research and better care for cancer patients on the island of Ireland and driving research and innovation in the US.</p></div>\",\"PeriodicalId\":38212,\"journal\":{\"name\":\"Journal of Cancer Policy\",\"volume\":\"38 \",\"pages\":\"Article 100448\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213538323000656\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538323000656","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
Health diplomacy in action: The cancer legacy of the Good Friday Agreement
2023 marks the 25th anniversary of the Good Friday Agreement, which led peace in Northern Ireland. As well as its impact on peace and reconciliation, the Good Friday Agreement has also had a lasting positive impact on cancer research and cancer care across the island of Ireland. Pursuant to the Good Friday Agreement, a Memorandum of Understanding (MOU) was signed between the respective Departments of Health in Ireland, Northern Ireland and the US National Cancer Institute (NCI), giving rise to the Ireland – Northern Ireland – National Cancer Institute Cancer Consortium, an unparalleled tripartite agreement designed to nurture and develop linkages between cancer researchers, physicians and allied healthcare professionals across Ireland, Northern Ireland and the US, delivering world class research and better care for cancer patients on the island of Ireland and driving research and innovation in the US.